Skip to main content
. 2019;20(6):1809–1815. doi: 10.31557/APJCP.2019.20.6.1809

Table 2.

Progression of Precancerous Cervical Lesion Associated with p16 IHC Staining

Total (%) Progressive/recurrent CIN2+ (%)
LSIL Negative p16 IHC 84 (77.7) 3 (3.6)
(N = 108) Positive p16 IHC 24 (22.2) 4 (16.7)
HSIL Negative p16 IHC 12 (15.2) 1 (8.3)
(N = 79) Positive p16 IHC 67 (84.8) 12 (17.9)

CIN2+, cervical intraepithelial neoplasia 2 or worse; p16 IHC, p16 protein-immunohistochemistry staining